CHINA HEALTH (Stock Code: 00673) has released its annual financial results for the period ending March 31, 2026.
The company reported revenue of HK$41.092 million, representing a year-on-year increase of 5.52%.
The net loss attributable to owners of the company was HK$47.932 million, which narrowed by 29.29% compared to the previous corresponding period.
The loss per share was HK$0.0496.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.